Susan Hasty, Publisher
Table of Contents . . . November 21st, 2003
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Angiogenesis Weekly | Other Publications
Lung Cancer - Second hand smoke fuels the growth of tumors and their blood vessels
Neuroscience - Dexamethasone suppresses angiogenesis in 9L gliosarcoma
Cancer Therapy - Anti-mouse VEGFR2 antibodies are useful for vascular targeting and imaging
Cancer Therapy - Immunotherapy and antiangiogenic therapy combine to reject tumors
Gastroenterology - The magnolia derivative magnolol possesses strong antimetastatic properties
Hematology - Endothelial precursor cells may be a better model for tumor endothelium
Cancer Metastasis - Tie-1 monoclonal antibodies detect angiogenesis in metastatic cancers
Cardiology - The depictions of tumor vessel physiology on MRI should not be misconstrued
Finance - Tissue regeneration company announces record third quarter results
Gynecology - Lysophosphatidic acid tends to accumulate in the ovarian cancer environment
Immunology - Recombinant antibody offers a new approach for halting tumor progression
Multiple Myeloma - The angiogenic response in CAM assays is sometimes time-dependent
Oncology - Interaction between perlecan protein core and progranulin may control cancer
Oncology - The molecular signature of bone marrow micrometastasis is distinctive
Oncology - The new agent FK228 is a selective suppressor of angiogenesis factors
Ophthalmology - Lutein supplementation prevents age-related macular degeneration
Personnel - Biopharma company appoints John A. Skolas CFO, general counsel, and secretary
Physiology - Vascular endothelial growth factor increases during compensatory hypertrophy
Prostate Cancer - The engagement of SPARC with tumor integrins favors cancer metastasis
Proteomics - Fibroblast growth factor-2 promotes tumor progression in a prostate cancer model
Rectal Cancer - NCI to conduct phase II clinical study using TNFerade
Reproductive Medicine - Granulosa cells generate signals that moderate follicular vascularity
Retinopathy - Ribozymes reduce preretinal neovascularization by cleaving mRNA
Stem-Cell Research - A mathematical model offers insight into the promise of antiangiogenic therapy
Tumors - Vinblastine halts adrenomedullin-induced angiogenic response
Tyrosine Kinase - Angiopoietin-1 participates in the kinetics of vascular network assembly
Wound Care - Company launches wound therapy system
Wound Care - New drugs stimulate therapeutic angiogenesis and promote wound healing
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.